Teva Pharmaceutical Industries | TEVA - Operating Expenses

Stock Price
9,330.00
Daily Change
91.00 0.99%
Monthly
-7.26%
Yearly
76.54%
Q2 Forecast
9,052.90

Teva Pharmaceutical Industries reported $4.22B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Aspen Pharmacare ZAR 13.32B 5.36B Dec/2025
Cipla INR 60.98B 1.06B Dec/2025
Dr.Reddys Laboratories INR 73.6B 1.79B Dec/2025
Guangzhou Baiy CNY 16.64B 1.79B Dec/2025
Jiangsu Hengrui CNY 6.12B 180.16M Dec/2025
Kalbe Farma IDR 8.06T 883.47B Sep/2025
Richter Gedeon HUF 151.11B 20.72B Sep/2025
Sh Fosun Pharma CNY 11.3B 2.18B Dec/2025
Sun Pharmaceuticals INR 111.11B 6.97B Sep/2025
Teva Pharmaceutical Industries USD 4.22B 812M Dec/2025